Despite considerable research efforts, pancreatic cancer is associated with a dire prognosis
and a 5-year survival rate of only 10%. Early symptoms of the disease are mostly …

Pancreatic cancer is currently the third leading cause of cancer death in the United States.
The clinical hallmarks of this disease include abdominal pain that radiates to the back, the …

Objective To determine the frequency of depression or anxiety preceding a diagnosis of
pancreatic cancer (PC). Further, to examine the association of PC‐associated depression or …

Introduction Most patients with pancreatic cancer present with advanced stage, incurable
disease. However, patients with high-grade precancerous lesions and many patients with …

Metabolites of tryptophan degradation are known to alter mood. Their effects have only been
superficially examined in the context of pancreatic cancer. Herein, we study the role of …

Pancreatic cancer is a highly devastating disease with high mortality rates. Even patients
who undergo potential curative surgery have a high risk for recurrence. The incidence of …

Background Major depressive disorder (MDD) and anxiety were recognized in treating
pancreatic ductal adenocarcinoma (PDAC). This longitudinal study identified risk factors for …

Background The rate of suicide within one year after diagnosis in pancreatic cancer patients
are high, but suicide studies based on the current large-scale data are still a vacancy. Our …

Pancreatic cancer is one of the few cancer types in the US with incidence and death rates
continuing to rise. As the disease threatens to become the second leading cause of cancer …

Background Familial pancreatic cancer touches families through a genetic susceptibility to
developing this neoplasia. Genetic susceptibility is assessed via family history, genetic …